Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Verastem, Inc. (VSTM)  
$13.16 1.14 (9.48%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 25,230,000
Market Cap: 332.03(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.8 - $14.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,735 21,833 25,311 165,018
Total Sell Value $18,442 $258,319 $292,764 $385,800
Total People Sold 4 4 4 4
Total Sell Transactions 9 20 37 63
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 268
  Page 8 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Westphal Christoph H Director   –       •       •   2014-01-07 4 A $0.00 $0 D/D 25,826 716,206     -
   Westphal Christoph H Director   –       •       •   2014-01-02 4 D $11.40 $74,009 D/D (6,492) 690,380     -
   Westphal Christoph H Director   –       •       •   2013-11-18 4 AB $9.60 $9,602 D/D 1,000 696,872     -
   Aldrich Richard Director   –       •       •   2013-11-11 4 AB $10.93 $10,930 I/I 1,000 20,000     -
   Aldrich Richard Director   –       •       •   2013-11-04 4 AB $10.51 $10,510 I/I 1,000 19,000     -
   Westphal Christoph H Director   –       •       •   2013-10-31 4 A $9.99 $7,996 D/D 800 695,872     -
   Aldrich Richard Director   –       •       •   2013-10-28 4 AB $11.26 $11,260 I/I 1,000 18,000     -
   Aldrich Richard Director   –       •       •   2013-10-21 4 AB $12.57 $12,570 I/I 1,000 17,000     -
   Aldrich Richard Director   –       •       •   2013-10-14 4 AB $10.56 $10,560 I/I 1,000 16,000     -
   Aldrich Richard Director   –       •       •   2013-10-07 4 AB $11.53 $11,530 I/I 1,000 15,000     -
   Westphal Christoph H Director   –       •       •   2013-09-30 4 D $12.71 $77,455 D/D (6,094) 695,072     -
   Aldrich Richard Director   –       •       •   2013-09-30 4 AB $12.55 $12,550 I/I 1,000 14,000     -
   Aldrich Richard Director   –       •       •   2013-09-23 4 AB $13.17 $13,170 I/I 1,000 13,000     -
   Aldrich Richard Director   –       •       •   2013-09-16 4 AB $13.81 $13,810 I/I 1,000 12,000     -
   Aldrich Richard Director   –       •       •   2013-09-09 4 AB $14.04 $14,040 I/I 1,000 11,000     -
   Aldrich Richard Director   –       •       •   2013-09-03 4 AB $14.07 $14,070 I/I 1,000 10,000     -
   Aldrich Richard Director   –       •       •   2013-08-26 4 AB $14.21 $14,210 I/I 1,000 9,000     -
   Aldrich Richard Director   –       •       •   2013-08-19 4 AB $13.45 $13,450 I/I 1,000 8,000     -
   Aldrich Richard Director   –       •       •   2013-08-12 4 AB $14.75 $14,750 I/I 1,000 7,000     -
   Aldrich Richard Director   –       •       •   2013-08-05 4 AB $15.25 $15,250 I/I 1,000 6,000     -
   Paterson Dan Chief Business Officer   •       –      –    2013-08-01 4 D $15.19 $99,783 D/D (6,569) 94,290     -
   Pachter Jonathan VP, Head of Research   •       –      –    2013-08-01 4 D $15.19 $74,309 D/D (4,892) 70,748     -
   Forrester Robert President and CEO   •       •      –    2013-08-01 4 D $15.19 $126,988 D/D (8,360) 246,614     -
   Aldrich Richard Director   –       •       •   2013-07-29 4 AB $15.15 $15,150 I/I 1,000 5,000     -
   Aldrich Richard Director   –       •       •   2013-07-24 4 AB $16.39 $16,390 I/I 1,000 4,000     -
  268 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us